Drug Trial Radar · NCT07227298
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
162
Planned (sponsor's estimate)
Start
Jan 30, 2026
Primary completion
Mar 8, 2029
Study completion Aug 23, 2033
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Nov 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be removed by surgery or cured with standard treatments. To join in the study, participants must: * Be 18 years or older * Participants with advanced non-small cell lung cancer (NSCLC), a type of lung cancer that has spread to other parts of the body The study will look at: * Whether PF-08634404 is safe to use with other cancer medicines. * What side effects may happen. A side effect is anything the medicine does to your body that is not part of treating your disease. * Whether the combination of PF-08634404 and other cancer medicines can help treat solid tumors. The study has different parts, each testing PF-08634404 with a different cancer medicine: * Part A will test PF-08634404 with a medicine called sigvotatug vedotin. * Part B will test PF-08634404 with a medicine called PF-08046054/SGN-PDL1V Participants will receive the study medicines through an intravenous (IV) infusion (injected into the vein) at the study clinic. All treatments will take place at clinical trial sites, where trained medical staff will monitor participants during and after each visit.
Conditions
- Advanced/Metastatic Non-Small Cell Lung Cancer
- Carcinoma, Non-Small Cell Lung
- Non-Small Cell Lung Cancer
Interventions
PF-08634404Biological
-Concentrate for solution for infusion
Sigvotatug VedotinBiological
-Powder for concentrate for solution for infusion. Single use vial
PF-08046054/SGN-PDL1VBiological
-Powder for concentrate for solution for infusion. Single use vial.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Through 90 days after the last study intervention; Up to approximately 5 years
- Phase I: Number of participants with dose limiting toxicity (DLT)Time frame: Through 90 days after the last study intervention; Up to approximately 5 years
- Phase 2: Confirmed Objective Response Rate (ORR) per RECIST v1.1 by investigatorTime frame: Up to approximately 5 Years
Locations
104 sites in 9 countries. Site status is shown where the registry gives one.
Highlands Oncology Group, PA
Fayetteville, Arkansas · Recruiting
Highlands Oncology Group, PA
Rogers, Arkansas · Recruiting
Highlands Oncology Group, PA
Springdale, Arkansas · Recruiting
Providence Medical Foundation
Fullerton, California · Recruiting
Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center
Fullerton, California · Recruiting
Providence St. Jude Medical Center
Fullerton, California · Recruiting
Scripps Clinic Torrey Pines (Scripps Cancer Center)
La Jolla, California · Recruiting
Scripps Green Hospital
La Jolla, California · Recruiting
Scripps Shiley Pavilion
La Jolla, California · Recruiting
START Los Angeles, LLC
Los Angeles, California · Recruiting
LACN Century City
Los Angeles, California · Recruiting
Valkyrie Clinical Trials (Additional Site Pharmacy Storage Suite)
Los Angeles, California · Recruiting
Valkyrie Clinical Trials (Additional Site Suite)
Los Angeles, California · Recruiting
Valkyrie Clinical Trials
Los Angeles, California · Recruiting
Mission Community Hospital (Satellite Site)
Panorama City, California · Recruiting
Rocky Mountain Cancer Centers,LLP
Aurora, Colorado · Recruiting
Rocky Mountain Cancer Centers,LLP
Denver, Colorado · Recruiting
Rocky Mountain Cancer Centers,LLP
Lone Tree, Colorado · Recruiting
BRCR Medical Center Inc.
Coral Springs, Florida · Recruiting
Moffitt Cancer Center- Speros
Land O' Lakes, Florida · Not yet recruiting
Mid Florida Hematology and Oncology Center
Orange City, Florida · Recruiting
Orlando Health Ambulatory Care Center
Orlando, Florida · Recruiting
Orlando Health Cancer Institute
Orlando, Florida · Recruiting
Orlando Health Orlando Regional Medical Center
Orlando, Florida · Recruiting
Moffitt Cancer Center - SouthShore
Ruskin, Florida · Not yet recruiting
BRCR Global - Tamarac
Tamarac, Florida · Recruiting
Moffitt Cancer Center - International Plaza
Tampa, Florida · Not yet recruiting
Moffitt Cancer Center - McKinley Campus
Tampa, Florida · Not yet recruiting
Moffitt Cancer Center
Tampa, Florida · Not yet recruiting
Moffitt McKinley Hospital
Tampa, Florida · Not yet recruiting
Moffitt Cancer Center - Wesley Chapel
Wesley Chapel, Florida · Not yet recruiting
Hackensack University Medical Center
Hackensack, New Jersey · Recruiting
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey · Recruiting
Newman Street Imaging
Hackensack, New Jersey · Recruiting
John Theurer Cancer Center at JSUMC
Neptune City, New Jersey · Recruiting
Jack & Sheryl Morris Cancer Center
New Brunswick, New Jersey · Not yet recruiting
Robert Wood Johnson University Hospital (RWJBH)
New Brunswick, New Jersey · Not yet recruiting
Robert Wood Johnson University Hospital
New Brunswick, New Jersey · Not yet recruiting
Rutgers Cancer Institute
New Brunswick, New Jersey · Not yet recruiting
John Theurer Cancer Center at From Road
Paramus, New Jersey · Recruiting
Showing 40 of 104 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.